Danny Yeung
Danny Yeung is best known as the co-founder and CEO of Prenetics, a Hong Kong-based genomics and health diagnostics company that became one of Asia's most prominent health-tech success stories, completing a SPAC merger with Artisan Acquisition Corp and listing on Nasdaq in 2022. His work at Prenetics — spanning consumer DNA testing through the CircleDNA brand and large-scale COVID-19 testing programs — demonstrated his ability to scale data-driven health platforms across Asia and beyond. This intersection of personal data, consumer engagement, and health personalization places him at the crossroads of health tech and data commerce. Yeung's entrepreneurial career spans multiple ventures across Asia, with earlier roles in digital commerce and consumer internet businesses. His background reflects a consistent focus on leveraging data and technology to deliver personalized consumer experiences — a skillset increasingly relevant to the AdTech and MarTech ecosystem as health and wellness brands invest heavily in first-party data strategies and direct-to-consumer engagement. His current venture, IM8, is a premium health and wellness supplement brand where he serves as CEO, continuing his focus on consumer health and personalized wellness. While not a traditional AdTech operator, Yeung's work is notable in the broader ecosystem for its emphasis on consumer data, identity, and personalized engagement at scale in Asian markets.
Last updated Aug 25, 2026 by ATDb automated enrichment
- Years in industry
- 15 years
Bio
Danny Yeung is best known as the co-founder and CEO of Prenetics, a Hong Kong-based genomics and health diagnostics company that became one of Asia's most prominent health-tech success stories, completing a SPAC merger with Artisan Acquisition Corp and listing on Nasdaq in 2022. His work at Prenetics — spanning consumer DNA testing through the CircleDNA brand and large-scale COVID-19 testing programs — demonstrated his ability to scale data-driven health platforms across Asia and beyond. This intersection of personal data, consumer engagement, and health personalization places him at the crossroads of health tech and data commerce. Yeung's entrepreneurial career spans multiple ventures across Asia, with earlier roles in digital commerce and consumer internet businesses. His background reflects a consistent focus on leveraging data and technology to deliver personalized consumer experiences — a skillset increasingly relevant to the AdTech and MarTech ecosystem as health and wellness brands invest heavily in first-party data strategies and direct-to-consumer engagement. His current venture, IM8, is a premium health and wellness supplement brand where he serves as CEO, continuing his focus on consumer health and personalized wellness. While not a traditional AdTech operator, Yeung's work is notable in the broader ecosystem for its emphasis on consumer data, identity, and personalized engagement at scale in Asian markets.
Career
Co-Founder & CEO
Prenetics · 2014-2023
CEO
CircleDNA (Prenetics brand) · 2019-2023
Co-Founder
Groupon Hong Kong / Fave (related ventures) · 2010-2014
Board memberships
Expertise & education
Expertise
Education
- University of Southern California (reported attendance)
Speaking topics
Recognition
Notable achievements
- Co-founded Prenetics and led its Nasdaq listing via SPAC merger with Artisan Acquisition Corp in 2022, one of the first Hong Kong health-tech companies to list in the US via this route
- Scaled CircleDNA into one of Asia's most recognized consumer DNA testing brands with global distribution
- Led Prenetics to conduct millions of COVID-19 tests across Hong Kong and the UK during the pandemic
- Founded IM8, a premium health supplement brand, continuing focus on personalized consumer wellness